Ceres Power Holdings PLC Logo

Ceres Power Holdings PLC

A developer of solid oxide technology for clean power and green hydrogen production.

CWR | IL

Overview

Corporate Details

ISIN(s):
GB00BG5KQW09 (+1 more)
LEI:
213800N7AAHSXQUOA733
Country:
United Kingdom
Address:
VIKING HOUSE, RH13 5PX HORSHAM

Description

Ceres Power is a developer of clean energy technology centered on its proprietary solid oxide platform. The company operates an asset-light licensing model, providing its solid oxide fuel cell (SOFC) and solid oxide electrolyzer cell (SOEC) technologies to global manufacturing partners. The SOFC technology enables highly efficient, fuel-flexible power generation for applications in data centers, commercial power, and industry. The SOEC technology is designed for the production of low-cost green hydrogen, a critical component for decarbonizing industrial processes, transportation, and creating green fuels like ammonia. Ceres collaborates with multinational corporations to embed its technology into their products, facilitating scalable deployment to address climate change.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-28 11:10
Total Voting Rights
English 9.4 KB
2025-11-06 16:20
Holding(s) in Company
English 27.7 KB
2025-11-05 08:25
Weichai signs manufacturing licence for SOFC power
English 13.4 KB
2025-10-31 17:15
Holding(s) in Company
English 58.6 KB
2025-10-15 11:00
Holding(s) in Company
English 29.8 KB
2025-10-07 10:30
Holding(s) in Company
English 28.7 KB
2025-10-03 12:30
Holding(s) in Company
English 58.8 KB
2025-10-02 08:01
Holding(s) in Company
English 27.5 KB
2025-10-02 08:00
Holding(s) in Company
English 27.7 KB
2025-09-30 11:00
Total Voting Rights
English 10.1 KB
2025-09-02 08:00
Notice of Interim Results
English 11.2 KB
2025-07-31 11:00
Total Voting Rights
English 10.0 KB
2025-07-28 08:00
Doosan Fuel Cell and Ceres joint announcement
English 15.0 KB
2025-07-10 17:05
Holding(s) in Company
English 29.4 KB
2025-07-09 18:25
Holding(s) in Company
English 28.9 KB

Automate Your Workflow. Get a real-time feed of all Ceres Power Holdings PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Ceres Power Holdings PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Ceres Power Holdings PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.